CRLCharles River Laboratories International, Inc.
Healthcare · Diagnostics & ResearchNYSEStockMkt cap $13.5B
Disclosed trades
9
0 in 30d · 0 in 90d
Politicians
5
Last trade May 15, 2025
Buys
5
$89K at range midpoints
Sells
4
$56.5K at range midpoints
Closing price · 365 days
Sep 24, 2025 – Sep 23, 2026
Monthly buys vs sells · 24 months
Counts of disclosed transactions
- Buys
- Sells (incl. partial)
Politicians who traded it
4 hold it now Estimated
| Politician | Seat | Trades | Buys | Sells | Bought (mid) | Sold (mid) | Last trade | Est. position Estimated |
|---|---|---|---|---|---|---|---|---|
| RJefferson Shreve | House · IN-06 | 2 | 1 | 1 | $32.5K | $32.5K | May 12, 2025 | $767 |
| DLois Frankel | House · FL-22 | 2 | 1 | 1 | $8K | $8K | Sep 8, 2023 | $719 |
| RRobert P. Bresnahan, Jr. | House · PA-08 | 2 | 1 | 1 | $32.5K | $8K | May 15, 2025 | $56.9K |
| DZoe Lofgren | House · CA-18 | 2 | 1 | 1 | $8K | $8K | Aug 25, 2022 | — |
| DJulie Johnson | House · TX-32 | 1 | 1 | 0 | $8K | $0 | Jan 15, 2025 | $12.8K |
Recent trades
| Politician | Ticker | Asset | Type | Owner | Amount | Traded | Filed | Source |
|---|---|---|---|---|---|---|---|---|
| RJefferson Shreve | CRL | Charles River Laboratories International, Inc. Common Stock (CRL) | Sell | Self | $15,001 - $50,000 | May 12, 2025 | Jun 22, 202541d | Filing |
| RJefferson Shreve | CRL | Charles River Laboratories International, Inc. Common Stock (CRL) | Buy | Self | $15,001 - $50,000 | May 8, 2025 | Jun 22, 202545d | Filing |
| RRobert P. Bresnahan, Jr. | CRL | Charles River Laboratories International, Inc. Common Stock (CRL) | Sell | Self | $1,001 - $15,000 | May 15, 2025 | May 31, 202516d | Filing |
| RRobert P. Bresnahan, Jr. | CRL | Charles River Laboratories International, Inc. Common Stock (CRL) | Buy | Self | $15,001 - $50,000 | Apr 8, 2025 | May 8, 202530d | Filing |
| DJulie Johnson | CRL | Charles River Laboratories International, Inc. Common Stock (CRL) | Buy | Joint | $1,001 - $15,000 | Jan 15, 2025 | Feb 12, 202528d | Filing |
| DLois Frankel | CRL | Charles River Laboratories International, Inc. (CRL) | Sell | Self | $1,001 - $15,000 | Sep 8, 2023 | Oct 10, 202332d | Filing |
| DLois Frankel | CRL | Charles River Laboratories International, Inc. (CRL) | Buy | Self | $1,001 - $15,000 | Apr 25, 2023 | May 19, 202324d | Filing |
| DZoe Lofgren | CRL | Charles River Laboratories International, Inc. (CRL) | Sell | Spouse | $1,001 - $15,000 | Aug 25, 2022 | Sep 13, 202219d | Filing |
| DZoe Lofgren | CRL | Charles River Laboratories International, Inc. (CRL) | Buy | Spouse | $1,001 - $15,000 | Sep 30, 2021 | Oct 7, 20217d | Filing |
Insider activity Filed
Insiders
24
Services-Commercial Physical & Biological Research
Open-market buys · 90d
0
$0 bought
Open-market sells · 90d
18
$42.6M sold
Net · 90d
-$42.6M
-$42.6M net over 12 months · last Aug 25, 2026
| Date | Insider | Kind | Security | Shares | Price | Value | Post-holdings | D/I | 10b5-1 | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 25, 2026filed Aug 27, 2026 | James C Foster | Exercise | Stock Options (Right to Buy)deriv. | −12,429 | $0.00 | — | 12,429 | D | 10b5-1 | 4 |
| Aug 25, 2026filed Aug 27, 2026 | James C Foster | Exercise | Stock Options (Right to Buy)deriv. | −21,132 | $0.00 | — | 7,044 | D | 10b5-1 | 4 |
| Aug 25, 2026filed Aug 27, 2026 | James C Foster | Sale | Common Stock | −33,561 | $300.00 | $10,068,300 | 31,596 | D | 10b5-1 | 4 |
| Aug 25, 2026filed Aug 27, 2026 | James C Foster | Exercise | Common Stock | 12,429 | $208.44 | $2,590,701 | 65,157 | D | 10b5-1 | 4 |
| Aug 25, 2026filed Aug 27, 2026 | James C Foster | Exercise | Common Stock | 21,132 | $194.12 | $4,102,144 | 52,728 | D | 10b5-1 | 4 |
| Aug 19, 2026filed Aug 20, 2026 | Birgit GirshickChief Executive Officer | Gift | Common Stock | −528 | $0.00 | $0 | 35,485 | D | — | 4 |
| Aug 19, 2026filed Aug 20, 2026 | Shannon M ParisottoCEVP, Disc & Safety Assessment | Exercise | Stock Options (Right to Buy)deriv. | −2,039 | $0.00 | — | 2,039 | D | 10b5-1 | 4 |
| Aug 19, 2026filed Aug 20, 2026 | Shannon M ParisottoCEVP, Disc & Safety Assessment | Sale | Common Stock | −2,039 | $294.12 | $599,711 | 4,807 | D | 10b5-1 | 4 |
| Aug 19, 2026filed Aug 20, 2026 | Shannon M ParisottoCEVP, Disc & Safety Assessment | Exercise | Common Stock | 2,039 | $194.12 | $395,811 | 6,846 | D | 10b5-1 | 4 |
| Aug 18, 2026filed Aug 20, 2026 | Nancy C Andrews | Exercise | Stock Options (Right to Buy)deriv. | −573 | $0.00 | — | 0 | D | — | 4 |
Shares, prices and post-transaction holdings are exactly as reported on SEC Form 4. Net figures count open-market buys minus open-market sales only (awards, exercises, withholding and gifts are excluded).
Unusual activity Estimated
- 51Exec buyFeb 20, 2025
CRL CEO Birgit Girshick bought $249K on the open market
Details
- Insider
- Birgit Girshick
- Company
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker
- CRL
- Tx kind
- open_market_buy
- Tx date
- Feb 20, 2025
- Shares
- 1,514
- Price
- $165
- Value
- $249.2K
- Is 10b5 1
- No